Time delays in starting thrombolytic therapy

Time Delays in Cosmic Ray Propagation

Cosmic Rays (CR) travel at speeds essentially indistinguishable from the speed of light. However whilst travelling through magnetic fields, both regular and turbulent, they are delayed behind the light since they are usually charged particles and their paths are not linear. Those delays can be so long that they are an impediment to correctly identifying sources which may be variable in time. Fu...

Thrombolytic therapy.

Thrombolytic therapy, which involves the administration of agents designed to increase fibrinolytic capacity, has been utilized in respiratory medicine for more than 50 years. A variety of agents have been used to effect thrombolysis, including urokinase plasminogen activator (uPA) and streptokinase. Tissue plasminogen activator (tPA) has also been used to effect thrombolysis. Both uPA and tPA ...

Thrombolytic Therapy.

The purpose of this communication is to review briefly the agents available at the present time for use in thrombolytic therapy and to indicate why we believe that at the present time streptokinase is the only suitable agent for extended clinical trial. An account will then be given of the use of streptokinase administered by local perfusion in the treatment of peripheral arterial occlusion and...

[Thrombolytic therapy].

Is time the overriding factor in thrombolytic therapy?

toid arthritis. Lancet 1994; 344: 1105–10. [10] Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149–53. [11] Hwang SJ, Ballantyne CM, Sharrett AR et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosi...